Ryohei Tanigawa

Title: Ryohei Tanigawa: Innovator in Pharmaceutical Treatments

Introduction

Ryohei Tanigawa is a notable inventor based in Chuo-ku, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in treatments for liver conditions. With a total of two patents to his name, Tanigawa's work focuses on innovative methods to improve patient care.

Latest Patents

Tanigawa's latest patents include a medicament containing pemafibrate, aimed at providing an effective treatment method for liver cirrhosis patients. This invention specifically addresses the need for a reduced dosage regimen of pemafibrate for patients with liver cirrhosis, distinguishing their treatment from those with normal liver function. Another significant patent is an agent for the treatment of primary biliary cirrhosis (PBC). This pharmaceutical composition contains a therapeutically effective amount of (R)-2-[3-[[N-(benzoxazol-2-yl)-N-3-(4-methoxyphenoxy)propyl]aminomethyl]phenoxy] butyric acid, along with its salts or solvates.

Career Highlights

Tanigawa is associated with Kowa Company Limited, where he continues to advance his research and development efforts. His work has been instrumental in creating innovative solutions for complex medical conditions, showcasing his dedication to improving healthcare outcomes.

Collaborations

Tanigawa has collaborated with notable colleagues such as Satoshi Kojima and Mitsumasa Nakamura. These partnerships have fostered a collaborative environment that enhances the development of new pharmaceutical treatments.

Conclusion

Ryohei Tanigawa's contributions to the field of pharmaceuticals, particularly in liver disease treatments, highlight his innovative spirit and commitment to patient care. His patents reflect a deep understanding of medical needs and a drive to create effective solutions.